pmal c2x expression vector (New England Biolabs)
New England Biolabs is a verified supplier 
New England Biolabs manufactures this product 
96
Structured Review
New England Biolabs
pmal c2x expression vector
Pmal C2x Expression Vector, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 3339 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pmal+c2x+vector/pMAL/bio_rxiv__64898__2026__03__05__709893-151-5-9
Average 96 stars, based on 3339 article reviews
Pmal C2x Expression Vector, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 3339 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pmal+c2x+vector/pMAL/bio_rxiv__64898__2026__03__05__709893-151-5-9
Average 96 stars, based on 3339 article reviews
pmal c2x expression vector - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Transformation Assay:Article Title: Cryo-EM Analysis of the Effect of Seeding with Brain-derived Aβ Amyloid Fibrils. Article Snippet: Aβ amyloid fibrils from Alzheimer’s brain tissue are polymorphic and structurally different from typical in vitro formed Aβ fibrils.. Here, we show that brain-derived (ex vivo) fibril structures can be proliferated by seeding in vitro.. The proliferation reaction is only efficient for one of the three abundant ex vivo Aβ fibril morphologies, which consists of two peptide stacks, while the inefficiently proliferated fibril morphologies contain four or six peptide stacks. Binding Assay:Article Title: Cryo-EM Analysis of the Effect of Seeding with Brain-derived Aβ Amyloid Fibrils. Article Snippet: Aβ amyloid fibrils from Alzheimer’s brain tissue are polymorphic and structurally different from typical in vitro formed Aβ fibrils.. Here, we show that brain-derived (ex vivo) fibril structures can be proliferated by seeding in vitro.. The proliferation reaction is only efficient for one of the three abundant ex vivo Aβ fibril morphologies, which consists of two peptide stacks, while the inefficiently proliferated fibril morphologies contain four or six peptide stacks. Article Title: Dynamics underlie the drug recognition mechanism by the efflux transporter EmrE Article Snippet: .. EmrE is fused to the C-terminal end of His-tagged maltose binding protein (MBP) and encoded in a Virus:Article Title: Cryo-EM Analysis of the Effect of Seeding with Brain-derived Aβ Amyloid Fibrils. Article Snippet: Aβ amyloid fibrils from Alzheimer’s brain tissue are polymorphic and structurally different from typical in vitro formed Aβ fibrils.. Here, we show that brain-derived (ex vivo) fibril structures can be proliferated by seeding in vitro.. The proliferation reaction is only efficient for one of the three abundant ex vivo Aβ fibril morphologies, which consists of two peptide stacks, while the inefficiently proliferated fibril morphologies contain four or six peptide stacks. Clone Assay:Article Title: Surface-Exposed Protein Moieties of Burkholderia cenocepacia J2315 in Microaerophilic and Aerobic Conditions Article Snippet: .. The resulting amplicons, ranging in size from 228 to 284 bp, were digested with EcoRI and SalI and cloned into the same cloning sites of the Article Title: Neutralizing IgG 4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy. Article Snippet: Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD, Nicole A. LaHood, MD, Orlee Marini-Rapoport, BA, Bijoya Karmakar, PhD, L ena Andrieux, MS, Brian Reese, BS, et al GRAPHICAL ABSTRACT Capsule summary: The authors identified the induction of neutralizing serum IgG4 antibodies to Ara h 2 are clinically relevant biomarkers of durable efficacy in oral immunotherapy.. J Allergy Clin Immunol 2024;nnn:nnn-nnn.. 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology https://doi.org/10.1016/j.jaci.2024.02.017 1 Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD,a Nicole A. LaHood,MD,a OrleeMarini-Rapoport, BA,a Bijoya Karmakar, PhD,a L ena Andrieux, MS,a,b Brian Reese, BS,a Sunny L. Sneed, BS,a Lars C. Pedersen, PhD,c Geoffrey A. Mueller, PhD,c and Sarita U. Patil, MDa Boston, Mass; Lyon, France; and Durham, NC Abbreviations used hFcεRIa mice: hFcεRIa1/mFcεRIa2/2 mice MGH: Massachusetts General Hospital nAb: Neutralizing antibody nArah2: Natural Ara h 2 Non-nAb: Nonneutralizing mAb OIT: Oral immunotherapy PBST: PBS–Tween 20 PCA: Passive cutaneous anaphylaxis Background: Clinical efficacy of oral immunotherapy (OIT) has been associated with the induction of blocking antibodies, particularly those capable of disrupting IgE-allergen interactions. Article Title: Surface-Exposed Protein Moieties of Burkholderia cenocepacia J2315 in Microaerophilic and Aerobic Conditions. Article Snippet: .. The resulting amplicons, ranging in size from 228 to 284 bp, were digested with EcoRI and SalI and cloned into the same cloning sites of the Article Title: The root nodule symbiosis regulator NIN exhibits broad DNA binding specificity conferred by an NLP-inherited motif. Article Snippet: .. All truncated and chimeric constructs were BamHIintroduced into the Cloning:Article Title: Surface-Exposed Protein Moieties of Burkholderia cenocepacia J2315 in Microaerophilic and Aerobic Conditions Article Snippet: .. The resulting amplicons, ranging in size from 228 to 284 bp, were digested with EcoRI and SalI and cloned into the same cloning sites of the Article Title: Surface-Exposed Protein Moieties of Burkholderia cenocepacia J2315 in Microaerophilic and Aerobic Conditions. Article Snippet: .. The resulting amplicons, ranging in size from 228 to 284 bp, were digested with EcoRI and SalI and cloned into the same cloning sites of the Construct:Article Title: Structural insights into the functional mechanism of the ubiquitin ligase E6AP Article Snippet: For constructs in the pFastBac vectors, recombinant proteins were expressed in Sf9 insect cells (Invitrogen, 11496015) using the Bac-to-Bac baculovirus expression system (ThermoFisher). .. For constructs in the Article Title: Structural insights into the functional mechanism of the ubiquitin ligase E6AP. Article Snippet: Protein expression and purification For constructs in the pFastBac vectors, recombinant proteins were expressed in Sf9 insect cells (Invitrogen, 11496015) using the Bac-toBac baculovirus expression system (ThermoFisher). .. For constructs in the Article Title: The root nodule symbiosis regulator NIN exhibits broad DNA binding specificity conferred by an NLP-inherited motif. Article Snippet: .. All truncated and chimeric constructs were BamHIintroduced into the Plasmid Preparation:Article Title: Structural insights into the functional mechanism of the ubiquitin ligase E6AP Article Snippet: For constructs in the pFastBac vectors, recombinant proteins were expressed in Sf9 insect cells (Invitrogen, 11496015) using the Bac-to-Bac baculovirus expression system (ThermoFisher). .. For constructs in the Article Title: Structural insights into the functional mechanism of the ubiquitin ligase E6AP. Article Snippet: Protein expression and purification For constructs in the pFastBac vectors, recombinant proteins were expressed in Sf9 insect cells (Invitrogen, 11496015) using the Bac-toBac baculovirus expression system (ThermoFisher). .. For constructs in the Article Title: The root nodule symbiosis regulator NIN exhibits broad DNA binding specificity conferred by an NLP-inherited motif. Article Snippet: .. All truncated and chimeric constructs were BamHIintroduced into the Recombinant:Article Title: Structural insights into the functional mechanism of the ubiquitin ligase E6AP Article Snippet: For constructs in the pFastBac vectors, recombinant proteins were expressed in Sf9 insect cells (Invitrogen, 11496015) using the Bac-to-Bac baculovirus expression system (ThermoFisher). .. For constructs in the Article Title: Neutralizing IgG 4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy. Article Snippet: Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD, Nicole A. LaHood, MD, Orlee Marini-Rapoport, BA, Bijoya Karmakar, PhD, L ena Andrieux, MS, Brian Reese, BS, et al GRAPHICAL ABSTRACT Capsule summary: The authors identified the induction of neutralizing serum IgG4 antibodies to Ara h 2 are clinically relevant biomarkers of durable efficacy in oral immunotherapy.. J Allergy Clin Immunol 2024;nnn:nnn-nnn.. 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology https://doi.org/10.1016/j.jaci.2024.02.017 1 Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD,a Nicole A. LaHood,MD,a OrleeMarini-Rapoport, BA,a Bijoya Karmakar, PhD,a L ena Andrieux, MS,a,b Brian Reese, BS,a Sunny L. Sneed, BS,a Lars C. Pedersen, PhD,c Geoffrey A. Mueller, PhD,c and Sarita U. Patil, MDa Boston, Mass; Lyon, France; and Durham, NC Abbreviations used hFcεRIa mice: hFcεRIa1/mFcεRIa2/2 mice MGH: Massachusetts General Hospital nAb: Neutralizing antibody nArah2: Natural Ara h 2 Non-nAb: Nonneutralizing mAb OIT: Oral immunotherapy PBST: PBS–Tween 20 PCA: Passive cutaneous anaphylaxis Background: Clinical efficacy of oral immunotherapy (OIT) has been associated with the induction of blocking antibodies, particularly those capable of disrupting IgE-allergen interactions. Article Title: Structural insights into the functional mechanism of the ubiquitin ligase E6AP. Article Snippet: Protein expression and purification For constructs in the pFastBac vectors, recombinant proteins were expressed in Sf9 insect cells (Invitrogen, 11496015) using the Bac-toBac baculovirus expression system (ThermoFisher). .. For constructs in the Expressing:Article Title: Neutralizing IgG 4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy. Article Snippet: Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD, Nicole A. LaHood, MD, Orlee Marini-Rapoport, BA, Bijoya Karmakar, PhD, L ena Andrieux, MS, Brian Reese, BS, et al GRAPHICAL ABSTRACT Capsule summary: The authors identified the induction of neutralizing serum IgG4 antibodies to Ara h 2 are clinically relevant biomarkers of durable efficacy in oral immunotherapy.. J Allergy Clin Immunol 2024;nnn:nnn-nnn.. 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology https://doi.org/10.1016/j.jaci.2024.02.017 1 Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD,a Nicole A. LaHood,MD,a OrleeMarini-Rapoport, BA,a Bijoya Karmakar, PhD,a L ena Andrieux, MS,a,b Brian Reese, BS,a Sunny L. Sneed, BS,a Lars C. Pedersen, PhD,c Geoffrey A. Mueller, PhD,c and Sarita U. Patil, MDa Boston, Mass; Lyon, France; and Durham, NC Abbreviations used hFcεRIa mice: hFcεRIa1/mFcεRIa2/2 mice MGH: Massachusetts General Hospital nAb: Neutralizing antibody nArah2: Natural Ara h 2 Non-nAb: Nonneutralizing mAb OIT: Oral immunotherapy PBST: PBS–Tween 20 PCA: Passive cutaneous anaphylaxis Background: Clinical efficacy of oral immunotherapy (OIT) has been associated with the induction of blocking antibodies, particularly those capable of disrupting IgE-allergen interactions. Purification:Article Title: Neutralizing IgG 4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy. Article Snippet: Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD, Nicole A. LaHood, MD, Orlee Marini-Rapoport, BA, Bijoya Karmakar, PhD, L ena Andrieux, MS, Brian Reese, BS, et al GRAPHICAL ABSTRACT Capsule summary: The authors identified the induction of neutralizing serum IgG4 antibodies to Ara h 2 are clinically relevant biomarkers of durable efficacy in oral immunotherapy.. J Allergy Clin Immunol 2024;nnn:nnn-nnn.. 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology https://doi.org/10.1016/j.jaci.2024.02.017 1 Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD,a Nicole A. LaHood,MD,a OrleeMarini-Rapoport, BA,a Bijoya Karmakar, PhD,a L ena Andrieux, MS,a,b Brian Reese, BS,a Sunny L. Sneed, BS,a Lars C. Pedersen, PhD,c Geoffrey A. Mueller, PhD,c and Sarita U. Patil, MDa Boston, Mass; Lyon, France; and Durham, NC Abbreviations used hFcεRIa mice: hFcεRIa1/mFcεRIa2/2 mice MGH: Massachusetts General Hospital nAb: Neutralizing antibody nArah2: Natural Ara h 2 Non-nAb: Nonneutralizing mAb OIT: Oral immunotherapy PBST: PBS–Tween 20 PCA: Passive cutaneous anaphylaxis Background: Clinical efficacy of oral immunotherapy (OIT) has been associated with the induction of blocking antibodies, particularly those capable of disrupting IgE-allergen interactions. Sequencing:Article Title: Neutralizing IgG 4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy. Article Snippet: Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD, Nicole A. LaHood, MD, Orlee Marini-Rapoport, BA, Bijoya Karmakar, PhD, L ena Andrieux, MS, Brian Reese, BS, et al GRAPHICAL ABSTRACT Capsule summary: The authors identified the induction of neutralizing serum IgG4 antibodies to Ara h 2 are clinically relevant biomarkers of durable efficacy in oral immunotherapy.. J Allergy Clin Immunol 2024;nnn:nnn-nnn.. 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology https://doi.org/10.1016/j.jaci.2024.02.017 1 Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD,a Nicole A. LaHood,MD,a OrleeMarini-Rapoport, BA,a Bijoya Karmakar, PhD,a L ena Andrieux, MS,a,b Brian Reese, BS,a Sunny L. Sneed, BS,a Lars C. Pedersen, PhD,c Geoffrey A. Mueller, PhD,c and Sarita U. Patil, MDa Boston, Mass; Lyon, France; and Durham, NC Abbreviations used hFcεRIa mice: hFcεRIa1/mFcεRIa2/2 mice MGH: Massachusetts General Hospital nAb: Neutralizing antibody nArah2: Natural Ara h 2 Non-nAb: Nonneutralizing mAb OIT: Oral immunotherapy PBST: PBS–Tween 20 PCA: Passive cutaneous anaphylaxis Background: Clinical efficacy of oral immunotherapy (OIT) has been associated with the induction of blocking antibodies, particularly those capable of disrupting IgE-allergen interactions. Modification:Article Title: Neutralizing IgG 4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy. Article Snippet: Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD, Nicole A. LaHood, MD, Orlee Marini-Rapoport, BA, Bijoya Karmakar, PhD, L ena Andrieux, MS, Brian Reese, BS, et al GRAPHICAL ABSTRACT Capsule summary: The authors identified the induction of neutralizing serum IgG4 antibodies to Ara h 2 are clinically relevant biomarkers of durable efficacy in oral immunotherapy.. J Allergy Clin Immunol 2024;nnn:nnn-nnn.. 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology https://doi.org/10.1016/j.jaci.2024.02.017 1 Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy Tarun Keswani, PhD,a Nicole A. LaHood,MD,a OrleeMarini-Rapoport, BA,a Bijoya Karmakar, PhD,a L ena Andrieux, MS,a,b Brian Reese, BS,a Sunny L. Sneed, BS,a Lars C. Pedersen, PhD,c Geoffrey A. Mueller, PhD,c and Sarita U. Patil, MDa Boston, Mass; Lyon, France; and Durham, NC Abbreviations used hFcεRIa mice: hFcεRIa1/mFcεRIa2/2 mice MGH: Massachusetts General Hospital nAb: Neutralizing antibody nArah2: Natural Ara h 2 Non-nAb: Nonneutralizing mAb OIT: Oral immunotherapy PBST: PBS–Tween 20 PCA: Passive cutaneous anaphylaxis Background: Clinical efficacy of oral immunotherapy (OIT) has been associated with the induction of blocking antibodies, particularly those capable of disrupting IgE-allergen interactions. |